Literature DB >> 12768374

Hemoperitoneum from a spontaneous rupture of a giant hemangioma of the liver: report of a case.

Nicola Corigliano1, Paolo Mercantini, Pietro Maria Amodio, Genoveffa Balducci, Salvatore Caterino, Giovanni Ramacciato, Vincenzo Ziparo.   

Abstract

Hemangioma is the most common benign tumor of the liver and it is often asymptomatic. Spontaneous or traumatic rupture, intratumoral bleeding, consumption coagulopathy, and rapid growth are mandatory surgical indications. We report a case of giant hemangioma of hepatic segments II and III, which presented as hemoperitoneum, and were treated successfully with preoperative transcatheter arterial embolization (TAE) and hepatic bisegmentectomy. A PubMed Medline search has identified up to now 32 cases of spontaneous rupture of hepatic hemangioma in adults (age >14 years) without a history of trauma, including the present case. Twenty-seven out of these were reviewed. Sixteen (84.2%) of 19 tumors of known size were giant hemangiomas (mean diameter 14.8 cm; range 6-25). Twenty-two (95.7%) patients underwent surgery. Thirteen patients (59.1%) had a resection, 5 (22.8%) were sutured, and 4 (18.1%) underwent tamponade. Three (23%) out of the 13 resected patients died. Four patients (30.8%) underwent TAE prior to elective hepatic resection without any operative mortality. Among the 5 sutured patients, 2 (40%) died as well as 3 (75%) out of 4 patients who underwent tamponade. The mortality rate of all surgery patients was 36.4% (8/22).

Entities:  

Mesh:

Year:  2003        PMID: 12768374     DOI: 10.1007/s10595-002-2514-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  24 in total

1.  Surgical Management for Giant liver Hemangiomas Greater Than 20 cm in Size.

Authors:  Hui Jiang; Zheyu Chen; Pankaj Prasoon; Hong Wu; Yong Zeng
Journal:  Gut Liver       Date:  2011-06-28       Impact factor: 4.519

2.  Laparoscopic radiofrequency ablation of hepatic cavernous hemangioma. A preliminary experience with 27 patients.

Authors:  R-F Fan; F-L Chai; G-X He; L-X Wei; R-Z Li; W-X Wan; M-D Bai; W-K Zhu; M-L Cao; H-M Li; S-Z Yan
Journal:  Surg Endosc       Date:  2005-12-09       Impact factor: 4.584

3.  Giant hepatic hemangioma presenting as gastric outlet obstruction.

Authors:  Cemalettin Aydin; Sami Akbulut; Koray Kutluturk; Aysegul Kahraman; Cuneyt Kayaalp; Sezai Yilmaz
Journal:  Int Surg       Date:  2013 Jan-Mar

Review 4.  Spontaneous rupture of hepatic hemangioma: a case report and literature review.

Authors:  Wei Zhao; Xiao Guo; Jiahong Dong
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  Spontaneous rupture of hepatic hemangiomas: A review of the literature.

Authors:  Marcelo Af Ribeiro; Francine Papaiordanou; Juliana M Gonçalves; Eleazar Chaib
Journal:  World J Hepatol       Date:  2010-12-27

6.  Recurrent giant hemangioma causing severe respiratory distress.

Authors:  Fabrizio Romano; Grazia Messinesi; Francesco Tana; Franco Uggeri
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

7.  Comparison of laparoscopic radiofrequency ablation versus open resection in the treatment of symptomatic-enlarging hepatic hemangiomas: a prospective study.

Authors:  Xiaowu Zhang; Lunan Yan; Bo Li; Tianfu Wen; Wentao Wang; Mingqing Xu; Yonggang Wei; Jiayin Yang
Journal:  Surg Endosc       Date:  2015-06-27       Impact factor: 4.584

8.  Transcatheter arterial embolization in the treatment of extensive maxillofacial hemangioma in children.

Authors:  Li Jianhong; Hu Xianliang; Jiang Xuewu
Journal:  World J Surg       Date:  2005-12       Impact factor: 3.352

9.  Successful liver resection in a giant hemangioma with intestinal obstruction after embolization.

Authors:  Ji-Xiang Zhou; Ji-Wei Huang; Hong Wu; Yong Zeng
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

10.  Spontaneous rupture of a giant hepatic hemangioma-report of a case.

Authors:  Shahana Gupta; Vikash Agarwal; Anadi Nath Acharya
Journal:  Indian J Surg       Date:  2011-05-21       Impact factor: 0.656

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.